QUEST DIAGNOSTICS INC (DGX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue TTM

0 4B 8B 12B Q3 '21: 11B Q4 '21: 10.8B Q1 '22: 10.7B Q2 '22: 10.6B Q3 '22: 10.3B Q4 '22: 9.9B Q1 '23: 9.6B Q2 '23: 9.5B Q3 '23: 9.3B Q4 '23: 9.3B Q1 '24: 9.3B Q2 '24: 9.3B Q3 '24: 9.5B Q4 '24: 9.9B Q1 '25: 10.2B Q2 '25: 10.5B Q3 '25: 10.8B Q4 '25: 11B Q1 '26: 11.3B Q2 '26: 11.6B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

0 1.5B 3B 4.5B Q1 '16: 2.9B Q2 '16: 2.9B Q3 '16: 2.9B Q4 '16: 2.9B Q1 '17: 2.8B Q2 '17: 2.8B Q3 '17: 2.7B Q4 '17: 2.7B Q1 '18: 2.7B Q2 '18: 2.7B Q3 '18: 2.7B Q4 '18: 2.6B Q1 '19: 2.6B Q2 '19: 2.6B Q3 '19: 2.6B Q4 '19: 2.7B Q1 '20: 2.6B Q2 '20: 2.5B Q3 '20: 3B Q4 '20: 3.6B Q2 '16 Q1 '17 Q4 '17 Q3 '18 Q2 '19 Q1 '20 Q4 '20

Operating Income TTM

0 900M 1.8B 2.7B Q3 '21: 2.6B Q4 '21: 2.4B Q1 '22: 2.2B Q2 '22: 2.1B Q3 '22: 1.8B Q4 '22: 1.4B Q1 '23: 1.2B Q2 '23: 1.2B Q3 '23: 1.1B Q4 '23: 1.3B Q1 '24: 1.3B Q2 '24: 1.3B Q3 '24: 1.3B Q4 '24: 1.3B Q1 '25: 1.4B Q2 '25: 1.5B Q3 '25: 1.5B Q4 '25: 1.6B Q1 '26: 1.6B Q2 '26: 1.6B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

0 800M 1.6B 2.4B Q3 '21: 2.2B Q4 '21: 2B Q1 '22: 1.9B Q2 '22: 1.5B Q3 '22: 1.2B Q4 '22: 946M Q1 '23: 793M Q2 '23: 794M Q3 '23: 763M Q4 '23: 854M Q1 '24: 846M Q2 '24: 840M Q3 '24: 841M Q4 '24: 871M Q1 '25: 897M Q2 '25: 950M Q3 '25: 969M Q4 '25: 992M Q1 '26: 1B Q2 '26: 1.1B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 3B 6B 9B Q3 '21: 6.6B Q4 '21: 6.6B Q1 '22: 6.6B Q2 '22: 6.6B Q3 '22: 6.6B Q4 '22: 6.5B Q1 '23: 6.4B Q2 '23: 6.3B Q3 '23: 6.2B Q4 '23: 6.2B Q1 '24: 6.2B Q2 '24: 6.3B Q3 '24: 6.4B Q4 '24: 6.6B Q1 '25: 6.8B Q2 '25: 7B Q3 '25: 7.2B Q4 '25: 7.4B Q1 '26: 7.5B Q2 '26: 7.7B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

0 800M 1.6B 2.4B Q3 '21: 2.3B Q4 '21: 2.2B Q1 '22: 2B Q2 '22: 1.9B Q3 '22: 1.9B Q4 '22: 1.7B Q1 '23: 1.3B Q2 '23: 1.4B Q3 '23: 1.1B Q4 '23: 1.3B Q1 '24: 1.3B Q2 '24: 1.2B Q3 '24: 1.4B Q4 '24: 1.3B Q1 '25: 1.5B Q2 '25: 1.7B Q3 '25: 1.9B Q4 '25: 1.9B Q1 '26: 1.9B Q2 '26: 1.9B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

0 700M 1.4B 2.1B Q3 '21: 1.9B Q4 '21: 1.8B Q1 '22: 1.6B Q2 '22: 1.6B Q3 '22: 1.5B Q4 '22: 1.3B Q1 '23: 864M Q2 '23: 878M Q3 '23: 596M Q4 '23: 864M Q1 '24: 947M Q2 '24: 875M Q3 '24: 1B Q4 '24: 909M Q1 '25: 1.1B Q2 '25: 1.2B Q3 '25: 1.4B Q4 '25: 1.4B Q1 '26: 1.3B Q2 '26: 1.3B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 50M 100M 150M Q1 '20: 135M Q2 '20: 136M Q3 '20: 137M Q1 '21: 135M Q2 '21: 127M Q3 '21: 125M Q1 '22: 121M Q2 '22: 119M Q3 '22: 118M Q1 '23: 113M Q2 '23: 114M Q3 '23: 114M Q1 '24: 112M Q2 '24: 112M Q3 '24: 113M Q1 '25: 113M Q2 '25: 113M Q3 '25: 113M Q1 '26: 112M Q2 '26: 112M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 6.00 12.00 18.00 Q3 '21: 16.65 Q4 '21: 15.58 Q1 '22: 15.04 Q2 '22: 12.04 Q3 '22: 10.19 Q4 '22: 7.97 Q1 '23: 6.83 Q2 '23: 6.92 Q3 '23: 6.71 Q4 '23: 7.49 Q1 '24: 7.43 Q2 '24: 7.41 Q3 '24: 7.44 Q4 '24: 7.69 Q1 '25: 7.91 Q2 '25: 8.35 Q3 '25: 8.52 Q4 '25: 8.75 Q1 '26: 9.05 Q2 '26: 9.42 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.